Vancomycin Hydrochloride Injection 500 mL Single-dose ADD-Vantage Vials, 10/Box

Vancomycin Hydrochloride Injection is an antibiotic used to treat severe bacterial infections, including methicillin-resistant Staphylococcus aureus (MRSA) and other gram-positive infections. It is administered intravenously in hospitals for serious infections that are not responsive to other antibiotics. Vancomycin works by inhibiting bacterial cell wall synthesis, ultimately killing the bacteria. It is crucial to monitor kidney function and hearing during treatment, as it can cause nephrotoxicity and ototoxicity. This medication is often a critical option in treating life-threatening infections.

Experience the cutting-edge in antimicrobial therapy with Pfizer Injectables' Vancomycin Hydrochloride Injection, designed for healthcare professionals who demand excellence in patient care. Presented in a 500 mL single-dose ADD-Vantage vial, this product is expertly formulated to combat serious bacterial infections effectively. Packaged in convenient sets of 10 vials per box, it ensures that healthcare facilities have ready access to this critical intervention.

Product Details and Features:

Active Ingredient: Each vial contains Vancomycin Hydrochloride, a potent antibiotic tailored for fighting multidrug-resistant gram-positive infections.
Volume and Packaging: Supplied as a 500 mL single-dose vial in ADD-Vantage system, packaged in boxes of 10, offering streamlined preparation for infusion therapy and reducing preparation time.
Indications: Primarily indicated for severe infections caused by methicillin-resistant Staphylococcus aureus (MRSA), as well as other serious or life-threatening infections where other antibiotics are not suitable.
Compatibility: The ADD-Vantage vial system promotes ease of use, allowing quick reconstitution in compatible diluents for efficient administration during inpatient treatment.
Pfizer Trust: Manufactured by Pfizer, ensuring adherence to the highest quality and safety standards in pharmaceutical manufacturing.

Mechanism of Action:

Vancomycin Hydrochloride is a glycopeptide antibiotic that inhibits bacterial cell wall synthesis. It acts by binding with high affinity to the D-alanyl-D-alanine terminus of cell wall precursor units, inhibiting cell wall peptidoglycan polymerization. This disruption ultimately disrupts cell wall integrity, leading to cell lysis and death in susceptible gram-positive bacteria.

Warnings:

• Allergies: Contraindicated in patients with known hypersensitivity to vancomycin or any component of the formulation.
  
• Renal Function: Exercise caution in patients with renal impairment, adjusting dosage accordingly to prevent toxicity.
  
• Infusion Reactions: Rapid infusion may result in reactions known as “Red Man Syndrome,” characterized by flushing or rash, typically managed by slowing the infusion rate.
  
• Ototoxicity and Nephrotoxicity: Risk increases with high serum concentrations or prolonged therapy; monitor blood levels and renal function periodically.
  
• Pregnancy and Nursing: Use during pregnancy only if clearly needed and if benefits justify the risks, as it is excreted in breast milk.

Side Effects:

Common side effects include:

• Infusion-related redness and rash
  
• Hypotension if infused too rapidly
  
• Phlebitis at the injection site

Serious side effects that require immediate medical attention include:

• Signs of nephrotoxicity (unusual fatigue, decrease in urine output)
  
• Ototoxicity symptoms (ringing in ears, hearing loss)
  
• Severe allergic reactions or anaphylaxis (rash, itching, difficulty breathing)

Conclusion:

The Vancomycin Hydrochloride Injection by Pfizer Injectables is an essential tool for clinicians battling serious bacterial infections, particularly those resistant to commonly used antibiotics. With its precise formulation and ease of use through the ADD-Vantage vial system, healthcare providers can ensure their patients receive timely and effective antimicrobial therapy.